Three Arch Management Iv, L.l.c. - Net Worth and Insider Trading
Three Arch Management Iv, L.l.c. Net Worth
The estimated net worth of Three Arch Management Iv, L.l.c. is at least $210,180 dollars as of 2024-11-13. Three Arch Management Iv, L.l.c. is the Director, 10% Owner of Concert Pharmaceuticals Inc and owns about 25,109 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $210,162. Three Arch Management Iv, L.l.c. is the 10% Owner of Nevro Corp and owns about 4 shares of Nevro Corp (NVRO) stock worth over $18. Three Arch Management Iv, L.l.c. is also the 10% Owner of Talphera Inc and owns about 0 shares of Talphera Inc (TLPH) stock worth over $0. Details can be seen in Three Arch Management Iv, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Three Arch Management Iv, L.l.c. has not made any transactions after 2014-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Three Arch Management Iv, L.l.c.
Three Arch Management Iv, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Three Arch Management Iv, L.l.c. owns 3 companies in total, including Concert Pharmaceuticals Inc (CNCE) , Nevro Corp (NVRO) , and Talphera Inc (TLPH) .
Insider Ownership Summary of Three Arch Management Iv, L.l.c.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2014-11-18 | director & 10 percent owner |
NVRO | Nevro Corp | 2014-11-05 | 10 percent owner |
TLPH | Talphera Inc | 2011-02-16 | 10 percent owner |
Three Arch Management Iv, L.l.c. Latest Holdings Summary
Three Arch Management Iv, L.l.c. currently owns a total of 3 stocks. Among these stocks, Three Arch Management Iv, L.l.c. owns 25,109 shares of Concert Pharmaceuticals Inc (CNCE) as of February 12, 2014, with a value of $210,162 and a weighting of 99.99%. Three Arch Management Iv, L.l.c. owns 4 shares of Nevro Corp (NVRO) as of November 5, 2014, with a value of $18 and a weighting of 0.01%. Three Arch Management Iv, L.l.c. also owns 0 shares of Talphera Inc (TLPH) as of February 16, 2011, with a value of $0 and a weighting of 0%.
Latest Holdings of Three Arch Management Iv, L.l.c.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 25,109 | 8.37 | 210,162 |
NVRO | Nevro Corp | 2014-11-05 | 4 | 4.45 | 18 |
TLPH | Talphera Inc | 2011-02-16 | 0 | 0.89 | 0 |
Holding Weightings of Three Arch Management Iv, L.l.c.
Three Arch Management Iv, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Three Arch Management Iv, L.l.c. has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on February 12, 2014, which brought Three Arch Management Iv, L.l.c. around $0.
According to the SEC Form 4 filings, Three Arch Management Iv, L.l.c. has made a total of 0 transactions in Nevro Corp (NVRO) over the past 5 years. The most-recent trade in Nevro Corp is the sale of 0 shares on November 5, 2014, which brought Three Arch Management Iv, L.l.c. around $0.
According to the SEC Form 4 filings, Three Arch Management Iv, L.l.c. has made a total of 0 transactions in Talphera Inc (TLPH) over the past 5 years. The most-recent trade in Talphera Inc is the acquisition of 64,490 shares on February 16, 2011, which cost Three Arch Management Iv, L.l.c. around $6 Million.
Insider Trading History of Three Arch Management Iv, L.l.c.
- 1
Three Arch Management Iv, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of Three Arch Management Iv, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Three Arch Management Iv, L.l.c. is -13.92%. GuruFocus also compares Three Arch Management Iv, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Three Arch Management Iv, L.l.c. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Three Arch Management Iv, L.l.c.'s insider trading performs compared to the benchmark.
Performance of Three Arch Management Iv, L.l.c.
Three Arch Management Iv, L.l.c. Ownership Network
Ownership Network List of Three Arch Management Iv, L.l.c.
Ownership Network Relation of Three Arch Management Iv, L.l.c.
Three Arch Management Iv, L.l.c. Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Three Arch Management Iv, L.l.c. is the director & 10 percent owner of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Three Arch Management Iv, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Three Arch Management Iv, L.l.c.. You might contact Three Arch Management Iv, L.l.c. via mailing address: 3200 Apline Road, Portola Valley Ca 94028.